The long-term goals of this project are to biochemically characterize and define the physiologic functions of transglutaminases in vascular cells. A sensitive transglutaminases assay utilizing 3H-putrescine incorporation into dimethyl casein and endogenous cellular proteins will be used to biochemically characterize the transglutaminase activity in cultured bovine aortic endothelial cells (ABAE) and vascular smooth muscle cells (VSM). The subcellular localization of the transglutaminase in vascular cells will also be determined, with assays of cytoplasm, crude membrane and nuclear fractions. The effects of Mg-ATP, calcium, calmodulin, ionic and osmotic strength on the transglutaminase activity in sonicates of cultured vascular cells will be studied. The effectfs of calcium, the electrophoretic mobility and fibrinogen cross-linking pattern of the ABAE cell sonicates suggest that the endothelial transglutaminase has properties unlike other previously describes tissue treanglutaminases. A procedure is outlined to isolate the vascular transglutaminase from either bovine aortic tissue or from large-scale tissue cultures of ABAE and VSM cells. The purified enzyme will be characterized by SDS-PAGE, agarose gel electrophoresis, and enzyme kinetics using various substrances. The ability of polyamines to serve as transglutaminase substrates in vascular cells will also be studied. The ability of 3H-putrescine or its metabolic products to be incorporated into transglutaminase-mediated linkages with protein-bound glutamine groups will be analyzed in confluent and non-confluent ABAE and VSM cells. The specific proteins which have transglutaminase-coupled radioactive polyamines will be analyzed by SDS-PAGE and autoradiography. The effect of lipoproteins on both ABAE and VSM transglutaminase activity will also be studied and correlated with their effects on cell growth. These studies are designed to provide further information on both the biochemistry of vascular transglutaminases and how they regulate cell proliferation. These data may further explain the role of transglutaminases in normal vascular proliferation involved in wound healing and in the pathologic vascular proliferation of atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032342-03
Application #
3343714
Study Section
Biochemistry Study Section (BIO)
Project Start
1983-09-30
Project End
1986-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Achyuthan, K E; Mary, A; Bhaerman, R et al. (1989) Consequences of terbium (III) binding on the conformation and enzymatic activity of guinea pig liver transglutaminase. Mol Cell Biochem 85:57-65
Sane, D C; Pizzo, S V; Greenberg, C S (1989) Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review. Am J Hematol 31:53-7
Mary, A; Achyuthan, K E; Greenberg, C S (1988) The binding of divalent metal ions to platelet factor XIII modulates its proteolysis by trypsin and thrombin. Arch Biochem Biophys 261:112-21
Achyuthan, K E; Mary, A; Greenberg, C S (1988) The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin. J Biol Chem 263:14296-301
Achyuthan, K E; Greenberg, C S (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262:1901-6
Greenberg, C S; Achyuthan, K E; Fenton 2nd, J W (1987) Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII. Blood 69:867-71
Greenberg, C S; Achyuthan, K E; Borowitz, M J et al. (1987) The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization. Blood 70:702-9
Greenberg, C S; Devine, D V; McCrae, K M (1987) Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Am J Clin Pathol 87:94-100
Achyuthan, K E; Dobson, J V; Greenberg, C S (1986) Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Biochim Biophys Acta 872:261-8
Devine, D V; Kinney, T R; Thomas, P F et al. (1986) Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood 68:317-9

Showing the most recent 10 out of 14 publications